BioSpace News Archive

Nuvectis Pharma, Inc. today announced that the U.S. Food and Drug Administration (“FDA”) cleared the Company’s Investigational New Drug Application (“IND”) for NXP900, which includes the Phase 1 clinical trial protocol.

Oxford Biomedica plc, a quality and innovation-led viral vector CDMO, announces the launch of its 4th generation lentiviral vector delivery system, TetraVectaTM.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, announced preliminary top-line data from the 25 mg cohort of its Phase 2, four-week, placebo-controlled, dose exploration trial of CTI-1601 in participants with Friedreich’s ataxia.

Centene Corporation announced that Alice Hm Chen, M.D., MPH, Centene’s Chief Health Officer, has been appointed as an Executive Forum co-chair of the Health Care Payment Learning & Action Network, an organization of public and private healthcare leaders committed to the use of thought leadership, strategic direction and efforts to accelerate adoption of alternative payment models.

Nusano, Inc. and PharmaLogic today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key events since the start of 2023.

Element Biosciences, Inc. announced it is now leveraging a new Amazon Omics feature, Ready2Run workflows, to provide simple, powerful, and cost-effective analysis workflows.

Leap Therapeutics, Inc. today reported financial results for first quarter ended March 31, 2023.

BrainStorm Cell Therapeutics Inc. today announced financial results for the quarter ended March 31, 2023 and provided a corporate update.

Can-Fite BioPharma Ltd. today announced its VP of Business Development, Dr. Sari Fishman, will participate in BioEquity Europe which takes place on May 14th – 16th, 2023 in Dublin, Ireland.